deliv mix result seri one-tim item weigh
sale off-set earn beat start top-lin sale
report organ came organ street
expect larg driven mix headwind includ
erp system upgrad mitg impact end quarter
resolv earli delay custom purchas cvg
custom buy pattern rtg bottom line cash ep
report cc came better consensu mix better
gm lower coupl better interest
tax guidanc front manag point
toward organ growth small step
call street impli full-year growth slightli
rang given far year ep guidanc exclud
rais previou rang step
street head quarter
manag provid guidanc mix top
bottom organ sale expect grow organ
full-year basi compar prior guidanc consensu
bottom-lin outlook rais exclud impact viru
howev new rang come
street
updat estim see sale report
organ factor headwind fx
benefit headwind translat
cash ep oper margin
sourc style exposur morgan quantit deriv strategi tabl compani data morgan estim
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
summari invest thesi valuat
past year weve seen signific turnaround
perform manag return
consist exceed expect importantli
materi improv gener
stick point mani investor next month
believ medtron grow least plu see
number underappreci data present
transform new product launch appear
fulli appreci street conserv leav
potenti catalyst see come upsid vs
forecast manag set appropri
conserv bar long-rang top-lin earn
progress june analyst day see meaning
upsid street estim year ahead potenti
multipl expans sustain execut
dec price target share
base price-to-earnings multipl slight discount
large-cap med-tech peer set appli calendar ep
million
cash-flow oper
margin growth
 morgan quantit deriv strategi perform driver compani data bloomberg morgan estim tabl
invest thesi valuat risk
past year weve seen signific turnaround perform
manag deliv four consecut beat-and-rais quarter
top- bottom-lin out-performance return consist exceed
expect importantli materi improv gener
stick point mani investor next month believ
grow least plu see number underappreci data
present transform new product launch appear fulli
appreci street conserv leav potenti catalyst
see come upsid vs forecast manag set appropri
conserv bar long-rang top-lin earn progress june
analyst day see meaning upsid street estim year ahead
potenti multipl expans sustain execut
dec price target share base price-to-earnings multipl
slight discount large-cap med-tech peer set appli calendar
ep estim see appropri given compani in-lin outlook
longer term off-set modest headwind near term
risk rate price
downsid risk includ slower growth and/or increas competit core end
market slower anticip adopt new technolog poor
deploy capit lack gener
medtron plc summari financi
cash equival
flow oper activ
o/w chang work capit
flow invest activ
sale
flow financ activ
net chang cash
adj free cash flow firm
compani report morgan estim
note million except per-shar data fiscal year end apr o/w
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect research analyst person view subject secur issuer
part research analyst compens directli indirectli relat specif recommend
view express research analyst report korea-bas research analyst list front cover applic
also certifi per kofia requir analysi made good faith view reflect opinion
without undu influenc intervent
author name within report research analyst unless otherwis specifi europ sector specialist may shown
report contact author report part research depart
